greeksoup/ stock research
Stock research / United States / RDY / Year to 31 March 2021

Dr. Reddy’s Laboratories Limited (RDY) annual results, year to 31 March 2021: revenue INR 189,722 million, from the 20-F

Dr. Reddy’s Laboratories Limited files a 20-F with the SEC once a year, in Indian rupees. In the year to 31 March 2021 it reported revenue of INR 189,722 million ($2.6 billion at the year's average rate), up 8.7% on the year before. Its profit attributable to shareholders was INR 17,238 million, down 11.6%, and diluted earnings per share INR 103.65.

Revenue
INR 189,722 million
+8.7% on the year
FY2016FY2021
Operating margin
12.8%
9.2% a year earlier
FY2016FY2021
Net income
INR 17,238 million
-11.6% on the year
FY2016FY2021
Diluted EPS
INR 103.65
-11.7% on the year
FY2016FY2021

this yearthe year beforeIn Indian rupees as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toMar 2020Mar 2021
Revenue174,600189,722
Cost of sales80,59186,645
Gross profit94,009103,077
Research and development15,41016,541
Selling, general and administrative50,12954,650
Operating profit15,99324,280
Finance costs983970
Profit before tax18,03226,413
Income tax-1,4669,175
Profit for the year19,49817,238
Profit attributable to shareholders19,49817,238
Filing20-F20-F
INR million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toMar 2020Mar 2021
Diluted EPS117.40103.65
Basic EPS117.63103.94
Filing20-F20-F

INR per ordinary share, as filed.

Cash flow

Year toMar 2020Mar 2021
Cash from operations29,84135,703
Purchase of property, plant and equipment4,8469,741
Free cash flow24,99525,962
Cash from investing-4,923-22,660
Cash from financing-25,159-298
Depreciation and amortisation12,47212,796
Buybacks4741,193
Dividends paid3,9164,147
Filing20-F20-F

INR million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toMar 2020Mar 2021
Funded by
Equity attributable to shareholders154,988173,062
Borrowings, as filed22,01130,299
Lease liabilities1,7873,363
Other liabilities53,45558,767
Total equity and liabilities232,241265,491
Owned
Property, plant and equipment52,33257,111
Goodwill3,9944,568
Other intangible assets27,65935,648
Cash and cash equivalents2,05314,829
Trade and other receivables50,27849,641
Inventories35,06645,412
Other assets60,85958,282
Total assets232,241265,491
Filing20-F20-F

INR million, at each fiscal year end.

Ratios on the filed lines

Year toMar 2020Mar 2021
Gross margin53.8%54.3%
Operating margin9.2%12.8%
Net margin11.2%9.1%
Free cash flow margin14.3%13.7%
Return on year-end equity12.6%10.0%
Effective tax rate-8.1%34.7%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 March 2021, filed 13 June 2023: the filing. The figures are in Indian rupees as filed.